Access to the latest Korean startup news and startup database for free

#Weekly Funding Overview
[April.20~ April.24]#FUNDING
| Company | Inudustry | Amount | Round | Investors |
|---|---|---|---|---|
| Intergravity | Space Infra Deep-tech | 8 billion | Pre-Series A | Stonebridge, Stick, Company K Partners, D.CAMP, KIBO |
| Elice Group | AI Full-stack | - | Dongkuk Holdings, GS Ventures | |
| Holiday Robotics | Humanoid Robots | 150 billion | Series A | IMM Investment, Atinum Investment, Stonebridge Ventures |
| Automata | Enterprise IT AI | 10.5 billion | Series A | IM Investment Partners, SBI Investment, IBK Capital, Samsung Securities, Linear VC, WeVentures |
| Point2 Technology | Data Transmission Tech | 100 billion | Series B | N Ventures, Maverick Silicon, UMC Capital |
| 3billion | AI Rare Disease Diagnosis | 30 billion | Kiwoom PE, Kiwoom Securities, GVA Asset Mgmt, IBK, Meritz Securities | |
| AMA | Virtual Idol Entertainment | 6.9 billion | Seed | SBVA, Korea Investment Partners, ReVentures, Uncore, Aurora World |
| Watt | Robot Delivery Solution | - | Series A | HB Investment, Yamato Holdings |
| MuaHeng | Inner Beauty | 1 billion | Pre-Series A | KH Venture Partners, Ulsan CCEI |
| Stress Solution | AI Digital Healthcare | 4.25 billion | Pre-Series A | Enlight Ventures, Daejeon Investment Finance, KODIT, IBK, Impact Foundation |
| Tentech | Aesthetic Equipment | 5 billion | E&Investment | |
| Dnotitia | Long-term Memory AI | 90 billion | Series A | Kiwoom Investment, Starting Line, Maple Investment Partners, Daesung Private Equity, Shinhan Venture Investment, Almus Investment, Elohim Partners, Kolon Investment, HB Investment, Tony Investment, SJ Investment Partners |
| Enhans | Enterprise Agentic AI | - | Naver Ventures | |
| Risk-X | Derivative Ops Automation | - | Seed | Seoul National University Technology Holdings |
| Arte Corporation | Women's Underwear | - | M&A | Mediquarters |
| B Media Company | Brand Documentary Magazine | - | M&A | Musinsa |
| DDH | AI Dental Diagnosis Solution | - | Series B | EAST GATE PARTNERS, J&P Medi Partners |
| Day1Dream | K-POP Entertainmen | - | Crit Ventures | |
| MediN Research | Bio | - | Grant | TIPS |
| GLINS | Mobility Electronics | - | Grant | Deeptech TIPS |
| Double Current | Humanoid Motor Drivers | - | Grant | TIPS |
| Mimetics | Bio-inspired Medical Patch | - | Pre-Series A | Evergreen Investment Partners, Sema Investment, Navion Partners |
| Fulcrum Technologies | AI E-commerce Automation | - | Seed | Primer |
#TREND ANALYSIS
Korea’s M&A Market Is Being Left Behind
In April alone, four funding rounds exceeding 100 billion won each closed in Korea, with capital flooding into deep tech sectors — AI semiconductors, biotech, and robotics. Total monthly investment is on the verge of surpassing 1 trillion won for the first time since 2022. By every measure, Korea’s startup investment scene is having a moment. But look at the M&A market, and a very different picture emerges.
Data compiled by Startup Recipe for Q1 2025 reveals a market dominated not by technology deals, but by consumer brands and food and beverage franchises. Mediquitous acquired women’s underwear brand Arte Corporation. Orchestra Private Equity bought budget coffee chain Mammoth Coffee Lab for 100 billion won. CJ Freshway acquired food ingredient marketplace Market Boro for 80.6 billion won. Goodaiglobal took K-beauty distributor Hansung USA at a 100 billion won valuation, while an Elevation Equity Partners consortium purchased F&B franchise Allday Fresh for 120 billion won.
Deals between technology companies? Virtually absent. Deal sizes tell a similar story. Among all publicly disclosed transactions, only a handful crossed the 100 billion won threshold. And the acquirers are almost exclusively private equity firms or platform startups. Samsung, LG, Kakao, Naver — the names that defined a previous era of conglomerate-driven dealmaking — do not appear on this quarter’s M&A list. This marks a sharp departure from years past, when large corporate acquisitions of startups were a regular, if modest, feature of the market.
Google acquired cloud security startup Wiz for $32 billion. Meta secured a 49% stake in AI data company Scale AI for $14.3 billion. OpenAI executed six acquisitions in an aggressive push to expand its portfolio. The pattern is unmistakable: established technology leaders are absorbing startups to deepen their capabilities, while emerging AI companies are acquiring other startups to grow faster.
This model — technology acquires technology, scale begets scale — has become the global standard. In Korea, it has all but disappeared.
What remains is a market that operates on a fundamentally different logic. Rather than tech companies acquiring tech startups, Korea’s M&A activity is driven by private equity cycling through consumer goods brands and franchise businesses. It is, in many ways, a perfectly functional market — just not one that generates the kind of dealmaking that expands technological capability or opens new global markets.
The implications extend beyond any single quarter’s deal count. When startups cannot realistically be acquired by domestic tech giants, exit pathways narrow. Entrepreneurs plan accordingly. Investors price accordingly. The virtuous cycle — where a successful exit funds the next generation of ambitious founders — becomes harder to sustain. It is hardly a surprise, then, that Korea’s fastest-growing AI unicorns are increasingly becoming acquisition targets for global companies rather than acquirers themselves. The capital is here. The ambition is here. The exit infrastructure, for now, is not.
The government has recognized the problem. Earlier this year, the Ministry of SMEs and Startups established a dedicated M&A category within its Fund of Funds program, launching a 200 billion won secondary fund and a 100 billion won M&A fund focused on SME succession. Regulatory changes easing CVC investment restrictions have also created a clearer path for large conglomerates to acquire VC portfolio companies.
The direction is right. But policy intent and deal flow are different things. For the current investment boom to produce a genuinely healthy ecosystem — one where capital doesn’t just flow in, but circulates — the speed at which these measures translate into actual transactions will be the decisive factor. The money is arriving. The question is whether the market is ready to put it to work in the right way.